MedTrace Logo

Oraverse Versus Laser

NCT05473858 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-04-06

No results posted yet for this study

Summary

clinically assess the reversal of articaine 4% of two different concentration of vasoconcentration soft-tissue local anesthesia in pediatric dentistry using Diode Laser and Oraverse

Conditions

  • Reversal of Local Anesthesia in Children

Interventions

DRUG

OraVerse Injectable Product

injection of oraverse,

DEVICE

diode laser

patient exposed to diode laser

OTHER

Anaesthesia only

Patient exposed to anaesthesia without any more intervention

Sponsors & Collaborators

  • sara nabil

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-10
Primary Completion
2026-04-10
Completion
2026-04-10
FDA Drug
Yes
FDA Device
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05473858 on ClinicalTrials.gov